SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS
Publication
, Conference
Peters, K; Congdon, K; Archer, G; Woodring, S; Jaggers, D; Lipp, E; Healy, P; Herndon, J; Soher, B; Vlahovic, G; Johnson, M; Randazzo, D ...
Published in: NEURO-ONCOLOGY
November 11, 2019
ATIM-31
Duke Scholars
Published In
NEURO-ONCOLOGY
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 11, 2019
Volume
21
Issue
suppl 6
Start / End Page
vi8 / vi8
Location
Phoenix, AZ
Publisher
OXFORD UNIV PRESS INC
Conference Name
24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K., Congdon, K., Archer, G., Woodring, S., Jaggers, D., Lipp, E., … Sampson, J. (2019). SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS. In NEURO-ONCOLOGY (Vol. 21, pp. vi8–vi8). Phoenix, AZ: OXFORD UNIV PRESS INC. https://doi.org/10.1093/neuonc/noz175.030
Peters, Katherine, Kendra Congdon, Gary Archer, Sarah Woodring, Denise Jaggers, Eric Lipp, Patrick Healy, et al. “SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS.” In NEURO-ONCOLOGY, 21:vi8–vi8. OXFORD UNIV PRESS INC, 2019. https://doi.org/10.1093/neuonc/noz175.030.
Peters K, Congdon K, Archer G, Woodring S, Jaggers D, Lipp E, et al. SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2019. p. vi8–vi8.
Peters, Katherine, et al. “SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS.” NEURO-ONCOLOGY, vol. 21, no. suppl 6, OXFORD UNIV PRESS INC, 2019, pp. vi8–vi8. Manual, doi:10.1093/neuonc/noz175.030.
Peters K, Congdon K, Archer G, Woodring S, Jaggers D, Lipp E, Healy P, Herndon J, Soher B, Vlahovic G, Johnson M, Randazzo D, Desjardins A, Friedman H, Friedman A, Ashley D, Yan H, Sampson J. SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2019. p. vi8–vi8.
Published In
NEURO-ONCOLOGY
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 11, 2019
Volume
21
Issue
suppl 6
Start / End Page
vi8 / vi8
Location
Phoenix, AZ
Publisher
OXFORD UNIV PRESS INC
Conference Name
24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences